Guillain-Barre syndrome: current understanding of the pathology (review)
| dc.contributor.author | Davydova, A. H. | |
| dc.contributor.author | Kurochkin, M. Yu. | |
| dc.contributor.author | Herasimchuk, T. S. | |
| dc.contributor.author | Kapustin, S. A. | |
| dc.contributor.author | Давидова, Анна Григорівна | |
| dc.contributor.author | Курочкін, Михайло Юрійович | |
| dc.contributor.author | Герасімчук, Тетяна Сергіївна | |
| dc.contributor.author | Капустін, Сергій Анатолійович | |
| dc.date.accessioned | 2023-06-15T11:08:56Z | |
| dc.date.available | 2023-06-15T11:08:56Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Guillain-Barré syndrome (GBS), also called acute inflammatory demyelinating polyneuropathy, is an acquired immune-mediated neuropathy, the development of which occurs due to an immune reaction to a previous immune-activating event (viral or bacterial infection, surgical intervention, etc.). It is the most common cause of acute neuromuscular weakness and paralysis worldwide. | uk_UK |
| dc.identifier.citation | Guillain-Barre syndrome: current understanding of the pathology (review) / A. Davydova, M. Kurochkin, T. Herasimchuk, S. Kapustin // Technologies and strategies for the implementation of scientific achievements : collection of scientific papers "Scientia" with Proceedings of the III International Scientific and Theoretical Conference April 28, 2023; Stockholm, Sweden. - Stockholm : European Scientific Platform, 2023. - С. 122-124. - https://doi.org/10.36074/scientia-28.04.2023. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/18950 | |
| dc.language.iso | en | uk_UK |
| dc.title | Guillain-Barre syndrome: current understanding of the pathology (review) | uk_UK |
| dc.type | Article | uk_UK |